{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:24:55Z","timestamp":1768559095706,"version":"3.49.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Malaria is a devasting parasitic disease that causes over half a million deaths every year. The necessity for prompt and thorough antimalarial drug discovery and development is accelerated by the rise in multidrug resistance and the lack of an effective vaccine. The <jats:italic>Plasmodium<\/jats:italic> spp. proteasome represents a prospective target for antimalarial treatment since several chemotherapy types have been shown to potently and selectively limit the growth of parasites. Combined with first-line artemisinin medicines, it creates synergy, even in the artemisinin-resistant parasites.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>PRISMA guidelines were used in the development of this systematic review. A literature search was performed in March 2024 in PubMed, Science Direct, and Scopus databases, with the following keywords: ((antimalarial resistance) AND (plasmodium OR malaria) AND (proteasome)) NOT (cancer [Title\/Abstract]). Only articles with the susceptibility assessment were included.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Herein, 35 articles were included in the systematic review, which was divided into two subcategories: those that studied the UPS inhibitors, which accounted for 25 articles, and those that studied genetic modifications, including knockouts, knockdowns, and mutations, in the UPS toward antimalarial resistance, accounting for 16 articles. 6 articles included both subcategories. In total, 16 categories of inhibitors were analyzed, together with two knockdowns, one knockout, and 35 mutations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this study, we reviewed the literature for available inhibitors and their respective susceptibility and ability to develop resistance toward <jats:italic>Plasmodium<\/jats:italic> spp. 26\u2009s proteasome. The proteasome was highlighted as a potential antimalarial target and as an artemisinin partner drug. However, host toxicity and susceptibility to resistance appear as the main obstacle in the development of highly potent drugs, indicating a need for additional scrutiny during any further drug development efforts.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1441352","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T04:35:14Z","timestamp":1729485314000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Ubiquitin-proteasome system in Plasmodium: a potential antimalarial target to overcome resistance \u2013 a systematic review"],"prefix":"10.3389","volume":"11","author":[{"given":"Adriana F.","family":"Gon\u00e7alves","sequence":"first","affiliation":[]},{"given":"Ana","family":"Lima-Pinheiro","sequence":"additional","affiliation":[]},{"given":"Pedro E.","family":"Ferreira","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"ref1","year":"2023"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"100024","DOI":"10.1016\/j.gene.2019.100024","article-title":"Putative circumsporozoite protein (CSP) of plasmodium vivax is considerably distinct from the well-known CSP and plays a role in the protein ubiquitination pathway","volume":"721","author":"Dash","year":"2019","journal-title":"Gene"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"129458","DOI":"10.1016\/j.bmcl.2023.129458","article-title":"Identification of covalent fragment inhibitors for plasmodium falciparum UCHL3 with anti-malarial efficacy","volume":"94","author":"Imhoff","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"8302","DOI":"10.1038\/s41467-023-44077-2","article-title":"Structures revealing mechanisms of resistance and collateral sensitivity of plasmodium falciparum to proteasome inhibitors","volume":"14","author":"Hsu","year":"2023","journal-title":"Nat Commun"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/1475-2875-13-452","article-title":"Artemisinin resistance \u2013 modelling the potential human and economic costs","volume":"13","author":"Lubell","year":"2014","journal-title":"Malar J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.pt.2013.05.002","article-title":"Artemisinin resistance in plasmodium falciparum: what is it really?","volume":"29","author":"Ferreira","year":"2013","journal-title":"Trends Parasitol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1128\/AAC.01868-12","article-title":"Reduced Artemisinin susceptibility of plasmodium falciparum ring stages in Western Cambodia","volume":"57","author":"Witkowski","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.chom.2017.11.005","article-title":"Inhibiting the plasmodium eIF2\u03b1 kinase PK4 prevents Artemisinin-induced latency","volume":"22","author":"Zhang","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1126\/science.1260403","article-title":"Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance","volume":"347","author":"Mok","year":"2015","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e1002132","DOI":"10.1371\/journal.pbio.1002132","article-title":"Targeting the cell stress response of plasmodium falciparum to overcome Artemisinin resistance","volume":"13","author":"Dogovski","year":"2015","journal-title":"PLoS Biol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nature14412","article-title":"A molecular mechanism of artemisinin resistance in plasmodium falciparum malaria","volume":"520","author":"Mbengue","year":"2015","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1093\/infdis\/jix156","article-title":"Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant Artemisinin-resistant plasmodium falciparum","volume":"215","author":"Siddiqui","year":"2017","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1038\/s41467-018-06221-1","article-title":"Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome","volume":"9","author":"Bridgford","year":"2018","journal-title":"Nat Commun"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"10675","DOI":"10.1038\/s41598-019-47034-6","article-title":"Comparative structural and evolutionary analyses predict functional sites in the artemisinin resistance malaria protein K13","volume":"9","author":"Copp\u00e9e","year":"2019","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e0501422","DOI":"10.1128\/spectrum.05014-22","article-title":"Chemogenomic profiling of a plasmodium falciparum transposon mutant library reveals shared effects of Dihydroartemisinin and Bortezomib on lipid metabolism and exported proteins","volume":"11","author":"Pires","year":"2023","journal-title":"Microbiol Spectr"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1021\/acsinfecdis.3c00310","article-title":"Covalent macrocyclic proteasome inhibitors mitigate resistance in plasmodium falciparum","volume":"9","author":"Bennett","year":"2023","journal-title":"ACS Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.trsl.2018.04.007","article-title":"The proteasome as a target to combat malaria: hits and misses","volume":"198","author":"Krishnan","year":"2018","journal-title":"Transl Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"17818","DOI":"10.1038\/srep17818","article-title":"Characterization of the 26S proteasome network in plasmodium falciparum","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-58971-4_1","article-title":"Structure, dynamics and function of the 26S proteasome","volume":"1","author":"Mao","year":"2021","journal-title":"Subcell Biochem"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.pt.2017.05.009","article-title":"Protein degradation systems as antimalarial therapeutic targets","volume":"33","author":"Ng","year":"2017","journal-title":"Trends Parasitol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nature16936","article-title":"Structure- and function-based design of plasmodium-selective proteasome inhibitors","volume":"530","author":"Li","year":"2016","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e202203958","DOI":"10.1002\/chem.202203958","article-title":"Development of potent and highly selective Epoxyketone-based plasmodium proteasome inhibitors. Chemistry \u2013 a","volume":"29","author":"Almaliti","year":"2023","journal-title":"Eur J"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1128\/AAC.01096-10","article-title":"Thiostrepton and derivatives exhibit antimalarial and Gametocytocidal activity by dually targeting parasite proteasome and Apicoplast","volume":"55","author":"Aminake","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"21486","DOI":"10.1073\/pnas.1216016110","article-title":"Targeting the ERAD pathway via inhibition of signal peptide peptidase for antiparasitic therapeutic design","volume":"109","author":"Harbut","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.exppara.2005.11.012","article-title":"Plasmodium falciparum: the fungal metabolite gliotoxin inhibits proteasome proteolytic activity and exerts a plasmodicidal effect on P. Falciparum","volume":"112","author":"Hatabu","year":"2006","journal-title":"Exp Parasitol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40360-017-0147-4","article-title":"Inhibitors of ubiquitin E3 ligase as potential new antimalarial drug leads","volume":"18","author":"Jain","year":"2017","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"E6863","DOI":"10.1073\/pnas.1806109115","article-title":"Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance","volume":"115","author":"Kirkman","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"133588","DOI":"10.1016\/j.molstruc.2022.133588","article-title":"Potency of copper(II) complexes towards drug-sensitive and -resistant plasmodium falciparum: structure-activity relationship, ROS-generation and proteasome inhibition","volume":"1267","author":"Lai","year":"","journal-title":"J Mol Struct"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12936-022-04406-0","article-title":"Dinuclear and mononuclear metal(II) polypyridyl complexes against drug-sensitive and drug-resistant plasmodium falciparum and their mode of action","volume":"21","author":"Lai","year":"","journal-title":"Malar J"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.1021\/acs.jmedchem.7b00671","article-title":"Development of a potent inhibitor of the plasmodium proteasome with reduced mammalian toxicity","volume":"60","author":"LaMonte","year":"2017","journal-title":"J Med Chem"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1021\/cb5001263","article-title":"Assessing subunit dependency of the plasmodium proteasome using small molecule inhibitors and active site probes","volume":"9","author":"Li","year":"2014","journal-title":"ACS Chem Biol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1021\/acsinfecdis.1c00110","article-title":"High throughput screening to identify selective and Nonpeptidomimetic proteasome inhibitors as Antimalarials","volume":"7","author":"Mata-Cantero","year":"2021","journal-title":"ACS Infect Dis"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e2335","DOI":"10.1371\/journal.pone.0002335","article-title":"Marine Actinomycetes: a new source of compounds against the human malaria parasite","volume":"3","author":"Prudhomme","year":"2008","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1472-6904-7-13","article-title":"Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B","volume":"7","author":"Reynolds","year":"2007","journal-title":"BMC Clin Pharmacol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1021\/acsinfecdis.0c00580","article-title":"Mammalian deubiquitinating enzyme inhibitors display in vitro and in vivo activity against malaria parasites and potentiate Artemisinin action","volume":"7","author":"Simwela","year":"2021","journal-title":"ACS Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1128\/AAC.00742-12","article-title":"Broad-Spectrum antimalarial activity of Peptido sulfonyl fluorides, a new class of proteasome inhibitors","volume":"57","author":"Tschan","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1021\/acs.jmedchem.2c01651","article-title":"Structure-activity relationship studies of antimalarial plasmodium proteasome inhibitors\u2500part II","volume":"66","author":"Zhang","year":"2023","journal-title":"J Med Chem"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3389\/fcimb.2024.1342856","article-title":"Mutation in the 26S proteasome regulatory subunit rpn2 gene in plasmodium falciparum confers resistance to artemisinin","volume":"14","author":"Gon\u00e7alves","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2926003","DOI":"10.21203\/rs.3.rs-2926003\/v1","article-title":"Parasite proteostasis and artemisinin resistance","volume":"1","author":"Rosenthal","year":"2023","journal-title":"Res Sq"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1021\/acsinfecdis.0c00900","article-title":"A proteasome mutation sensitizes P. Falciparum Cam3.II K13 C580Y parasites to DHA and OZ439","volume":"7","author":"Rosenthal","year":"2021","journal-title":"ACS Infect Dis"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1128\/mBio.02312-20","article-title":"Plasmodium berghei K13 mutations mediate in vivo Artemisinin resistance that is reversed by proteasome inhibition","volume":"11","author":"Simwela","year":"2020","journal-title":"MBio"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e0082122","DOI":"10.1128\/aac.00821-22","article-title":"A plasmodium falciparum RING finger E3 ubiquitin ligase modifies the roles of PfMDR1 and PfCRT in parasite drug responses","volume":"67","author":"Singh","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijpara.2022.11.007","article-title":"Plasmodium DDI1 is a potential therapeutic target and important chromatin-associated protein","volume":"53","author":"Tanneru","year":"2023","journal-title":"Int J Parasitol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.pt.2020.03.006","article-title":"K13, the Cytostome, and Artemisinin resistance","volume":"36","author":"Xie","year":"2020","journal-title":"Trends Parasitol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.chembiol.2023.03.002","article-title":"Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the plasmodium proteasome","volume":"30","author":"Deni","year":"2023","journal-title":"Cell Chem Biol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e0081722","DOI":"10.1128\/aac.00817-22","article-title":"Susceptibilities of Ugandan plasmodium falciparum isolates to proteasome inhibitors","volume":"66","author":"Garg","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e1007722","DOI":"10.1371\/journal.ppat.1007722","article-title":"Covalent plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents","volume":"15","author":"Stokes","year":"2019","journal-title":"PLoS Pathog"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.1021\/acs.jmedchem.9b00363","article-title":"Improvement of asparagine Ethylenediamines as anti-malarial plasmodium -selective proteasome inhibitors","volume":"62","author":"Zhan","year":"2019","journal-title":"J Med Chem"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"9279","DOI":"10.1002\/anie.202015845","article-title":"Development of a highly selective plasmodium falciparum proteasome inhibitor with anti-malaria activity in humanized mice","volume":"60","author":"Zhan","year":"2021","journal-title":"Angew Chem Int Ed"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1038\/s41564-019-0524-4","article-title":"The structure of the PA28\u201320S proteasome complex from plasmodium falciparum and implications for proteostasis","volume":"4","author":"Xie","year":"2019","journal-title":"Nat Microbiol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","article-title":"Antimalarial drug discovery: progress and approaches","volume":"22","author":"Siqueira-Neto","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.pt.2021.01.009","article-title":"MalDA, accelerating malaria","volume":"37","author":"Yang","year":"2021","journal-title":"Drug Discov."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.pt.2021.04.006","article-title":"Assessing risks of plasmodium falciparum resistance to select next-generation antimalarials","volume":"37","author":"Duffey","year":"2021","journal-title":"Trends Parasitol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1126\/science.aax4735","article-title":"A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites","volume":"367","author":"Birnbaum","year":"2020","journal-title":"Science"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1016\/j.celrep.2019.10.095","article-title":"Decreased K13 abundance reduces hemoglobin catabolism and Proteotoxic stress, underpinning Artemisinin resistance","volume":"29","author":"Yang","year":"2019","journal-title":"Cell Rep"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0217-z","article-title":"Mortality attributable to plasmodium vivax malaria: a clinical audit from Papua, Indonesia","volume":"12","author":"Douglas","year":"2014","journal-title":"BMC Med"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1073\/pnas.1216457110","article-title":"Adaptation of the genetically tractable malaria pathogen plasmodium knowlesi to continuous culture in human erythrocytes","volume":"110","author":"Moon","year":"2013","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1441352\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T04:35:16Z","timestamp":1729485316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1441352\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":59,"alternative-id":["10.3389\/fmed.2024.1441352"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1441352","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"article-number":"1441352"}}